Sharpin contributes to TNFα dependent NFκB activation and Anti-Apoptotic signalling in hepatocytes

PLoS ONE

Volumn 7, Issue 1, 2012, Pages

  Sieber, Sabrina ^a   Lange, Nicole ^a   Kollmorgen, Gwendlyn ^a   Erhardt, Annette ^a   Quaas, Alexander ^a   Gontarewicz, Arthur ^a   Sass, Gabriele ^a   Tiegs, Gisa ^a   Kreienkamp, Hans Jürgen ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 8; GENOMIC DNA; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TUMOR NECROSIS FACTOR ALPHA; LIPOPOLYSACCHARIDE; NERVE PROTEIN; PAUL PROTEIN, MOUSE; SHARPIN; UBIQUITIN; UBIQUITIN PROTEIN LIGASE;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LIVER CELL; MOUSE; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; UBIQUITINATION; ANIMAL; ANTIBODY SPECIFICITY; C57BL MOUSE; DRUG EFFECT; GENE EXPRESSION PROFILING; GENETICS; LIVER FAILURE; METABOLISM; PATHOLOGY; PROTEIN BINDING; RAT; SIGNAL TRANSDUCTION;

MUS;

ANIMALS; APOPTOSIS; GENE EXPRESSION PROFILING; HEPATOCYTES; HUMANS; LIPOPOLYSACCHARIDES; LIVER FAILURE; MICE; MICE, INBRED C57BL; NERVE TISSUE PROTEINS; NF-KAPPA B; ORGAN SPECIFICITY; PROTEIN BINDING; RATS; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA; UBIQUITIN; UBIQUITIN-PROTEIN LIGASES;

EID: 84855473519     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0029993     Document Type: Article

References (25)

1. Karin M, Greten FR, (2005) NF-κB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 5: 749-759.
2. Hayden MS, Ghosh S, (2008) Shared principles in NF-κB signaling. Cell 132: 344-362.
3. Pasparakis M, (2009) Regulation of tissue homeostasis by NF-κB signalling: implications for inflammatory diseases. Nat Rev Immunol 9: 778-788.
4. Ikeda F, Crosetto N, Dikic I, (2010) What determines the specificity and outcomes of ubiquitin signaling? Cell 143: 677-681.
5. Iwai K, Tokunaga F, (2009) Linear polyubiquitination: a new regulator of NF-κB activation. EMBO Rep 10: 706-713.
6. Kirisako T, Kamei K, Murata S, Kato M, Fukumoto H, et al. (2006) A ubiquitin ligase complex assembles linear polyubiquitin chains. Embo J 25: 4877-4887.
7. Haas TL, Emmerich CH, Gerlach B, Schmukle AC, Cordier SM, et al. (2009) Recruitment of the linear ubiquitin chain assembly complex stabilizes the TNF-R1 signaling complex and is required for TNF-mediated gene induction. Mol Cell 36: 831-844.
8. Tokunaga F, Sakata S, Saeki Y, Satomi Y, Kirisako T, et al. (2009) Involvement of linear polyubiquitylation of NEMO in NF-κB activation. Nat Cell Biol 11: 123-132.
9. Lim S, Sala C, Yoon J, Park S, Kuroda S, et al. (2001) Sharpin, a novel postsynaptic density protein that directly interacts with the shank family of proteins. Mol Cell Neurosci 17: 385-397.
10. Seymour RE, Hasham MG, Cox GA, Shultz LD, Hogenesch H, et al. (2007) Spontaneous mutations in the mouse Sharpin gene result in multiorgan inflammation, immune system dysregulation and dermatitis. Genes Immun 8: 416-421.
11. HogenEsch H, Janke S, Boggess D, Sundberg JP, (1999) Absence of Peyer's patches and abnormal lymphoid architecture in chronic proliferative dermatitis (cpdm/cpdm) mice. J Immunol 162: 3890-3896.
12. Liang Y, Seymour RE, Sundberg JP, (2011) Inhibition of NF-κB signaling retards eosinophilic dermatitis in SHARPIN-deficient mice. J Invest Dermatol 131: 141-149.
13. Gerlach B, Cordier SM, Schmukle AC, Emmerich CH, Rieser E, et al. (2011) Linear ubiquitination prevents inflammation and regulates immune signalling. Nature 471: 591-596.
14. Ikeda F, Deribe YL, Skanland SS, Stieglitz B, Grabbe C, et al. (2011) SHARPIN forms a linear ubiquitin ligase complex regulating NF-κB activity and apoptosis. Nature 471: 637-641.
15. Tokunaga F, Nakagawa T, Nakahara M, Saeki Y, Taniguchi M, et al. (2011) SHARPIN is a component of the NF-κB-activating linear ubiquitin chain assembly complex. Nature 471: 633-636.
16. Leist M, Gantner F, Bohlinger I, Tiegs G, Germann PG, et al. (1995) Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models. Am J Pathol 1995 146: 1220-1234.
17. Gijbels MJ, Zurcher C, Kraal G, Elliott GR, HogenEsch H, et al. (1996) Pathogenesis of skin lesions in mice with chronic proliferative dermatitis (cpdm/cpdm). Am J Pathol 148: 941-950.
18. Leist M, Gantner F, Bohlinger I, Germann PG, Tiegs G, et al. (1994) Murine hepatocyte apoptosis induced in vitro and in vivo by TNF-α requires transcriptional arrest. J Immunol 153: 1778-1788.
19. Sass G, Shembade ND, Haimerl F, Lamoureux N, Hashemolhosseini S, et al. (2007) TNF pretreatment interferes with mitochondrial apoptosis in the mouse liver by A20-mediated down-regulation of Bax. J Immunol 179: 7042-7049.
20. Beg AA, Sha WC, Bronson RT, Ghosh S, Baltimore D, (1995) Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB. Nature 376: 167-170.
21. Luedde T, Beraza N, Kotsikoris V, van Loo G, Nenci A, et al. (2007) Deletion of NEMO/IKKγ in liver parenchymal cells causes steatohepatitis and hepatocellular carcinoma. Cancer Cell 11: 119-132.
22. Haimerl F, Erhardt A, Sass G, Tiegs G, (2009) Down-regulation of the de-ubiquitinating enzyme ubiquitin-specific protease 2 contributes to tumor necrosis factor-α-induced hepatocyte survival. J Biol Chem 284: 495-504.
23. Seglen PO, (1973) Preparation of rat liver cells. 3. Enzymatic requirements for tissue dispersion. Exp Cell Res 82: 391-398.
24. Bergmeyer HU, (1984) Methods of enzymatic analysis, 3rd edition, Vol. 82 Weinheim, Germany Verlag Chemie pp. 416-456.
25. Erhardt A, Biburger M, Papadopoulos T, Tiegs G, (2007) IL-10, regulatory T cells, and Kupffer cells mediate tolerance in concanavalin A-induced liver injury in mice. Hepatology 45: 475-485.